Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus.

Newcastle disease virus Raman spectroscopy cancer resistance drug resistance single cells

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
28 Jan 2023
Historique:
received: 25 11 2022
revised: 19 01 2023
accepted: 25 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 12 2 2023
Statut: epublish

Résumé

Newcastle disease virus (NDV) is an oncolytic agent against various types of mammalian cancers. As with all cancer therapies, the development of cancer resistance, both innate and acquired, is becoming a challenge. In this study, we investigated persistently NDV-infected Caco-2 colon cancer cells, designated as virus-resistant (VR) Caco-2 cells, which were then able to resist NDV-mediated oncolysis. We applied single-cell Raman spectroscopy, combined with deuterium isotope probing (Raman-DIP) techniques, to investigate the metabolic adaptations and dynamics in VR Caco-2 cells. A linear discriminant analysis (LDA) model demonstrated excellent performance in differentiating VR Caco-2 from Caco-2 cells at single-cell level. By comparing the metabolic profiles in a time-resolved manner, the de novo synthesis of proteins and lipids was found upregulated, along with decreased DNA synthesis in VR Caco-2. The results suggest that VR Caco-2 cells might reprogram their metabolism and divert energy from proliferation to protein synthesis and lipidic modulation. The ability to identify and characterise single resistant cells among a population of cancer cells would help develop a deeper understanding of the resistance mechanisms and better tactics for developing effective cancer treatment.

Identifiants

pubmed: 36765769
pii: cancers15030811
doi: 10.3390/cancers15030811
pmc: PMC9913782
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Engineering and Physical Sciences Research Council
ID : EP/M002403/1 and EP/M02833X/1
Organisme : Natural Environment Research Council
ID : NE/M002934/1
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/I/00007032, BBS/E/I/00007032, BBS/E/I/00007039, and BB/R007896/1 and BBSRC New-ton Fund supported Joint Centre Awards on "UK-China Centre of Excellence for Research on Avian Diseases" (BBS/OS/NW/000007) and UK-India Joint Centre on Animal Technology
Pays : United Kingdom

Références

Nat Biomed Eng. 2019 May;3(5):402-413
pubmed: 31036888
Anal Chem. 2000 Nov 15;72(22):5529-34
pubmed: 11101227
Anal Chem. 2017 Jun 20;89(12):6336-6340
pubmed: 28541039
Anal Chem. 2004 Aug 1;76(15):4452-8
pubmed: 15283587
Arch Gesamte Virusforsch. 1957;7(4):403-11
pubmed: 13521956
Virol J. 2014 May 16;11:91
pubmed: 24886301
Biophys J. 2018 Mar 27;114(6):1499-1511
pubmed: 29590606
Laryngoscope. 2000 Oct;110(10 Pt 1):1756-63
pubmed: 11037840
J Biomed Opt. 2009 Sep-Oct;14(5):054031
pubmed: 19895133
Microsc Res Tech. 2005 Oct;68(2):75-9
pubmed: 16228983
Sci Transl Med. 2019 Apr 17;11(488):
pubmed: 30996079
Nature. 2021 Aug;596(7873):576-582
pubmed: 34381210
Cancers (Basel). 2021 Apr 05;13(7):
pubmed: 33916413
Curr Opin Biotechnol. 2016 Oct;41:34-42
pubmed: 27149160
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E194-203
pubmed: 25550518
Nat Commun. 2016 Feb 19;7:10690
pubmed: 26891683
J Cell Commun Signal. 2018 Mar;12(1):133-141
pubmed: 29192388
Nat Commun. 2018 Aug 6;9(1):2995
pubmed: 30082908
Virus Res. 2014 May 12;184:71-81
pubmed: 24589707
J Virol. 2017 Jul 27;91(16):
pubmed: 28592535
Br J Cancer. 2011 Jan 18;104(2):290-9
pubmed: 21179029
BMC Cancer. 2021 May 27;21(1):625
pubmed: 34044804
Cancer Gene Ther. 2002 Dec;9(12):961-6
pubmed: 12522435
Anal Chem. 2021 Feb 2;93(4):2125-2134
pubmed: 33435684
Environ Microbiol. 2020 Jul;22(7):2613-2624
pubmed: 32114713
Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11624-9
pubmed: 26324899
Spectrochim Acta A Mol Biomol Spectrosc. 2017 Oct 5;185:317-335
pubmed: 28599236
Radiat Res. 2002 Feb;157(2):175-82
pubmed: 11835681
Anal Chem. 2019 Jun 18;91(12):7729-7737
pubmed: 31117406

Auteurs

Tong Yu (T)

Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK.

Archana Chandrabhan Jadhav (AC)

Beamline B24, Diamond Light Source, Harwell Science and Innovation Campus, Oxfordshire OX11 0DE, UK.
Viral Oncogenesis Group, The Pirbright Institute, Surrey GU24 0NF, UK.

Jiabao Xu (J)

Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK.

Adrian L Harris (AL)

Molecular Oncology Laboratories, Department of Oncology, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford University, Oxford OX3 9DS, UK.

Venugopal Nair (V)

Viral Oncogenesis Group, The Pirbright Institute, Surrey GU24 0NF, UK.
Department of Biology, University of Oxford, 11a Mansfield Road, Oxford OX1 3SZ, UK.

Wei E Huang (WE)

Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK.

Classifications MeSH